ThinkSabio

$MIRM

$87.03▲ +1.4% YTD

8 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History
News
MIRM ▲ +1.4% - Mirum Pharmaceuticals, Inc.
CP $87.03▲ +1.4%Nov 3, 2026 · ThinkSabio Blog

$MIRM reported Q3 2026 EPS of -$0.87, missing the -$0.44 estimate by 97.7%. Revenue of $185.7M beat the $177.7M estimate by 4.5%…

News
MIRM ▲ +0.0% - Mirum Pharmaceuticals, Inc.
CP $85.00▲ +0.0%Nov 2, 2026 · ThinkSabio Blog

$MIRM Mirum Pharmaceuticals Showcases Momentum Across Rare Liver Disease Portfolio with New Data at AASLD’s The Liver Meeting® 2026…

News
MIRM ▲ +5.3% - Mirum Pharmaceuticals, Inc.
CP $90.40▲ +5.3%Oct 12, 2026 · ThinkSabio Blog

$MIRM Mirum Pharmaceuticals: Phase 3 EXPAND Trial of LIVMARLI Meets Primary Endpoint; Shares Rise 6.1% Premarket ? • LIVMARLI significantly improved c…

News
MIRM ▲ +8.7% - Mirum Pharmaceuticals, Inc.
CP $93.40▲ +8.7%Oct 12, 2026 · ThinkSabio Blog

$MIRM Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases…

News
MIRM ▲ +5.1% - Mirum Pharmaceuticals, Inc.
CP $94.25▲ +5.1%Sep 28, 2026 · ThinkSabio Blog

$MIRM Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus…

News
MIRM ▲ +2.2% - Mirum Pharmaceuticals, Inc.
CP $91.30▲ +2.2%Sep 27, 2026 · ThinkSabio Blog

$MIRM Mirum Pharmaceuticals: Phase 3 AZURE-1 Topline Results for Brelovitug Due Sept. 28 ? • Investor call scheduled for 8:30 a.m. ET to present Phase…

SEC 13D/G
MIRM - Mirum Pharmaceuticals, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified
$99.05▲ 27.00%Aug 13, 2026 · ThinkSabio Blog

$MIRM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MIRM Mirum Pharmaceuticals, Inc. : $99.05 Sector: Healthcare |…

SEC 13D/G
MIRM - Mirum Pharmaceuticals, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified
$94.96▲ 21.76%Aug 6, 2026 · ThinkSabio Blog

$MIRM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MIRM Mirum Pharmaceuticals, Inc. : $94.96 Sector: Healthcare |…